Middeldorp S - Search Results

1

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--No.

Middeldorp S. Middeldorp S. J Thromb Haemost. 2003 Oct;1(10):2073-4. doi: 10.1046/j.1538-7836.2003.00503.x. J Thromb Haemost. 2003. PMID: 14521585 Free article. No abstract available.

2

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.

Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR. Middeldorp S, et al. Thromb Haemost. 2000 Jul;84(1):4-8. Thromb Haemost. 2000. PMID: 10928461 Clinical Trial.

3

Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.

Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN. Meijers JC, et al. Among authors: middeldorp s. Thromb Haemost. 2000 Jul;84(1):9-14. Thromb Haemost. 2000. PMID: 10928462 Clinical Trial.

4

How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation.

Middeldorp S, Büller HR. Middeldorp S, et al. Thromb Haemost. 2000 Nov;84(5):740-1. Thromb Haemost. 2000. PMID: 11127847 No abstract available.

5

Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications.

Middeldorp S, van de Poel MH, Bank I, Hamulyák K, Libourel EJ, Koopman MM, Prins MH, van der Meer J, Büller HR. Middeldorp S, et al. Thromb Haemost. 2004 Oct;92(4):787-90. doi: 10.1160/TH04-03-0198. Thromb Haemost. 2004. PMID: 15467909

6

Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis.

Bank I, Tick LW, Hutten BA, Kramer MH, Middeldorp S, Büller HR. Bank I, et al. Among authors: middeldorp s. Pathophysiol Haemost Thromb. 2003 Jul-2004 Aug;33(4):192-6. doi: 10.1159/000081507. Pathophysiol Haemost Thromb. 2003. PMID: 15583448 Free article.

7

Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences.

Locadia M, Bossuyt PM, Stalmeier PF, Sprangers MA, van Dongen CJ, Middeldorp S, Bank I, van der Meer J, Hamulyák K, Prins MH. Locadia M, et al. Among authors: middeldorp s. Thromb Haemost. 2004 Dec;92(6):1336-41. doi: 10.1160/TH04-02-0075. Thromb Haemost. 2004. PMID: 15583742

8

Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis.

Bank I, Libourel EJ, Middeldorp S, Hamulyák K, van Pampus EC, Koopman MM, Prins MH, van der Meer J, Büller HR. Bank I, et al. Among authors: middeldorp s. J Thromb Haemost. 2005 Jan;3(1):79-84. doi: 10.1111/j.1538-7836.2004.01033.x. J Thromb Haemost. 2005. PMID: 15634269 Free article.

9

Treatment of venous thromboembolism.

Buller HR, Sohne M, Middeldorp S. Buller HR, et al. Among authors: middeldorp s. J Thromb Haemost. 2005 Aug;3(8):1554-60. doi: 10.1111/j.1538-7836.2005.01414.x. J Thromb Haemost. 2005. PMID: 16102019 Free article. Review.

10

[Recurrent miscarriage and thrombophilia].

Middeldorp S, Goddijn M. Middeldorp S, et al. Ned Tijdschr Geneeskd. 2006 Jan 28;150(4):189-93. Ned Tijdschr Geneeskd. 2006. PMID: 16471233 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

460 results

Search Page